Evrenzo (roxadustat)

$210.21$695.76

Evrenzo (roxadustat) is a medication used for the treatment of anemia associated with chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients.

DISEASE INDICATIONS

Anemia

MANUFACTURER

Astellas Pharma Inc.

FibroGen

USAGE

Intravenous

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Pharmaceuticals and Medical Devices Agency (PMDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
EVRENZO (ROXADUSTAT) Package

30 tablets of 20 mg, 12 tablets of 20 mg, 12 tablets of 50 mg, 30 tablets of 50 mg, 30 tablets of 100 mg

Reviews

There are no reviews yet.

Be the first to review “Evrenzo (roxadustat)”

Your email address will not be published. Required fields are marked *

Shopping Cart